An interventional study of physical training in Lipid Metabolism, Insulin Resistance and Inflammation, sponsored by Vorarlberg Institute for Vascular Investigation and Treatment. Completed at 1 site in Austria. Open to participants aged 30 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2006-10-12.
Sponsored by Vorarlberg Institute for Vascular Investigation and Treatment · Not applicable, Interventional, and Educational/counseling/training
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Insulin Resistance with a site in Austria — 2 open to participants now, 3 under way, none of them phase 3. Insulin Resistance · Austria.
Among the 28 studies in Insulin Resistance with a site in Austria, this one is the 7th largest by enrollment of the 22 interventional ones that give a count, is one of 2 that started in 2003, is one of 15 with no phase, and was the 1st registered.
2,974 studies on the registry are indexed under Insulin Resistance; 336 are open to participants now.
Browse Insulin Resistance studies →2 of the 28 studies in Insulin Resistance with a site in Austria are open now. Recruiting first, the newest first:
FH Joanneum Gesellschaft mbH · Sites in Austria
Ages 21+ · Healthy volunteers
Medical University of Graz · Sites in Austria
Ages 18+ · Women only
A study can be open while its sites in Austria have not opened yet or have stopped. Only those recruiting at a site in Austria →
Of the 241 Insulin Resistance studies recruiting now, 52 (22%) set no upper age limit and 157 (65%) stop at 75 or younger; 28 take children under 18; 112 take healthy volunteers.
This study: 30 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
First in 1999; this study’s year is marked. 2 started in 2003.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 40 is close to the median of 40 across 2,371 interventional studies indexed under Insulin Resistance.
Median enrollment 27 across the 22 interventional studies, 33 across the 6 observational. Of the 22 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 28 have an industry lead sponsor. The 10 most frequent:
Vorarlberg Institute for Vascular Investigation and Treatment is the lead sponsor of 4 studies on the registry; 2 are open to participants now.
Vorarlberg Institute for Vascular Investigation and Treatment has 1 study filed under Insulin Resistance — fewer than ten, so there is no comparison to draw.
1 of the studies in Insulin Resistance with a site in Austria that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07440147FH Joanneum Gesellschaft mbHEffects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers | 2027-10 |
Add it to your calendar (.ics) → With an account.
Among the 28 studies in Insulin Resistance with a site in Austria, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to evaluate the metabolic and anti-inflammatory effects of eccentric endurance exercise and to compare them with those of concentric exercise in healthy sedentary individuals.
Physical exercise decreases the risk of obesity, diabetes mellitus, and cardiovascular disease. Skeletal muscle can be exercised by two ways: Concentric contraction is defined as active shortening of muscles, e.g. by stepping upwards, whereas eccentric muscle contraction is defined as active resistance to stretching, e.g. by stepping downwards. Although the effects of exercise (i.e. the combination of concentric and eccentric muscle contraction) on metabolic parameters have been extensively investigated, there are no data on the specific metabolic effects of concentric versus those of eccentric muscle work in humans.
Comparison(s): Metabolic and anti-inflammatory effects of eccentric endurance exercise (i.e. stepping upwards), compared to metabolic and anti-inflammatory effects of concentric exercise (i.e. stepping downwards).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Metabolic and anti-inflammatory effects induced by eccentric muscle exercise.
Metabolic and anti-inflammatory effects induced by concentric muscle exercise.
The record gives a start of Apr 2003 and a completion of Aug 2003. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2006. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Vorarlberg Institute for Vascular Investigation and Treatment